Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,827 | -29,815 | -42,350 | -33,152 | -14,730 |
| Depreciation Amortization | 252 | 228 | 236 | 250 | 255 |
| Accounts receivable | 111 | -6 | 48 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,332 | -1,042 | 799 | 509 | -527 |
| Other Working Capital | 2,412 | -778 | 79 | 1,387 | -285 |
| Other Operating Activity | 5,950 | 6,934 | 3,619 | 1,566 | 1,813 |
| Operating Cash Flow | $-29,770 | $-24,479 | $-37,569 | $-29,440 | $-13,474 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -21,580 | N/A | N/A | N/A | N/A |
| PPE Investments | N/A | -21 | N/A | N/A | -17 |
| Investing Cash Flow | $-21,580 | $-21 | $N/A | $N/A | $-17 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 1,330 | N/A | N/A |
| Debt Repayment | -18,109 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 860 | 197 | 18,032 | 338 | 3,231 |
| Other Financing Activity | 65,776 | 15,081 | -47 | 36,272 | 29,449 |
| Financing Cash Flow | $48,527 | $15,278 | $19,315 | $36,610 | $32,680 |
| Exchange Rate Effect | N/A | -3 | 3 | -1 | N/A |
| Beginning Cash Position | 15,596 | 24,821 | 43,072 | 35,903 | 16,714 |
| End Cash Position | 12,773 | 15,596 | 24,821 | 43,072 | 35,903 |
| Net Cash Flow | $-2,823 | $-9,225 | $-18,251 | $7,169 | $19,189 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,770 | -24,479 | -37,569 | -29,440 | -13,474 |
| Capital Expenditure | N/A | -21 | N/A | N/A | -17 |
| Free Cash Flow | -29,770 | -24,500 | -37,569 | -29,440 | -13,491 |